Literature DB >> 35806876

Laryngopharyngeal Reflux: The Last Decade.

Petros D Karkos1, Jerome R Lechien2.   

Abstract

Laryngopharyngeal reflux (LPR) and its consequences for the upper aerodigestive tract have been an issue of debate and controversy for more than three decades [...].

Entities:  

Year:  2022        PMID: 35806876      PMCID: PMC9267816          DOI: 10.3390/jcm11133592

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.964


Laryngopharyngeal reflux (LPR) and its consequences for the upper aerodigestive tract have been an issue of debate and controversy for more than three decades. From diagnosis to treatment, researchers and clinicians have been arguing on topics such as nomenclature, ideal diagnostics, pepsin, acid and alkaline components, symptom and finding questionnaires, ideal anti-reflux strategies and therapeutic duration. How do we define and, more importantly, how we treat something we “do not see” or “how do we treat symptoms with a multifactorial cause including reflux”? There have also been many papers providing “exercises” in evidence-based medicine over the years, with all reaching completely opposite conclusions. A typical focus of several systematic reviews and metanalyses is the eternal question on the empiric treatment of LPR with proton pump inhibitors: does it work or not [1,2,3]? In the last decade, there has been much emphasis on diagnostic algorithms for LPR, and this added to the disbelief in the classic strategy of empirical LPR treatment and whether this is still a valid treatment option 4. In the pediatric LPR world, it is even more crucial to reach a consensus on diagnosis and treatment, as the evidence of the link between severe upper respiratory problems, e.g., subglottic stenosis and acid, is strong. The aim of this Special Issue (SI) is to highlight weaknesses in the way we approached atypical reflux patients in the past and, more importantly, to offer new theories, knowledge and, hopefully, evidence on how to change our perspectives on LPR diagnosis and treatment. Reflux questionnaires and a search for better and easier-to-use approach especially in primary care, impedance and ph-monitoring, as well as custom-tailored strategies beyond the classic PPI treatment for LPR, will be discussed in detail [4,5]. Hopefully, this SI will help clinicians to formulate a concise plan to approach the LPR patient in a more systematic way.
  5 in total

Review 1.  Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review.

Authors:  Petros D Karkos; Janet A Wilson
Journal:  Laryngoscope       Date:  2006-01       Impact factor: 3.325

2.  Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Authors:  Jerome R Lechien; Sven Saussez; Antonio Schindler; Petros D Karkos; Abdul Latif Hamdan; Bernard Harmegnies; Lisa G De Marrez; Camille Finck; Fabrice Journe; Marianne Paesmans; Michael F Vaezi
Journal:  Laryngoscope       Date:  2018-12-30       Impact factor: 3.325

Review 3.  The development of new clinical instruments in laryngopharyngeal reflux disease: The international project of young otolaryngologists of the International Federation of Oto-rhino-laryngological Societies.

Authors:  J R Lechien; A Schindler; A L Hamdan; F Bobin; M R Barillari; B Harmegnies; D Dequanter; A Rodriguez; E Bartaire; T Ayad; P Karkos; L Crevier-Buchman; C Finck; S Saussez
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2018-08-28       Impact factor: 2.080

4.  The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance-pH monitoring in patients with acid, non-acid and mixed laryngopharyngeal reflux.

Authors:  Jérôme R Lechien; Francois Bobin; Vinciane Muls; Francois Mouawad; Didier Dequanter; Mihaela Horoi; Marie-Paule Thill; Alexandra Rodriguez Ruiz; Sven Saussez
Journal:  Clin Otolaryngol       Date:  2021-02-10       Impact factor: 2.597

5.  Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial.

Authors:  James O'Hara; Deborah D Stocken; Gillian C Watson; Tony Fouweather; Julian McGlashan; Kenneth MacKenzie; Paul Carding; Yakubu Karagama; Ruth Wood; Janet A Wilson
Journal:  BMJ       Date:  2021-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.